CoChat

Personalized medicine and back–allogeneic exosomes for cancer immunotherapy

Open access
Samuel, M., Gabrielsson, S. · 2021 · Journal of Internal Medicine
Cited by 70

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Extracellular vesicles, especially exosomes, have been explored for cancer immunotherapy. The initial studies made use of autologous B‐cell or dendritic cell‐derived exosomes, with the idea that MHC–peptide complexes on the exosomal surface would stimulate an MHC‐restricted cancer‐specific immune response. This was also verified in mouse systems, whilst the effects in human clinical systems were more modest. Several studies have explored the mechanisms for exosomal T‐cell activation, and a picture emerges where the antigen‐presenting cells, possibly both B cells and dendritic cells of the recipient, are needed to induce a potent T‐cell response to exosomes. Therefore, the exosomes function more as an adjuvant‐like delivery system of antigens, and we need to further understand the exact components that trigger the most broad and potent immune responses. Here, we describe the grounds for using allogeneic exosomes for cancer therapy, something that would greatly improve the feasibility of new exosome‐based immunotherapeutic approaches to cure cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.12963

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 70

Metadata

Authors
Samuel, M., & Gabrielsson, S.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2019-08-29
Volume
289
Issue
2
Pages
138-146
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2966273234
Cited by
70
References
5
FWCI
2.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Personalized medicine and back–allogeneic exosomes for cancer immunotherapy. https://app.cochat.ai/papers/10.1111/joim.12963
The paper
Samuel, M., & Gabrielsson, S. (2021). Personalized medicine and back–allogeneic exosomes for cancer immunotherapy. Journal of Internal Medicine. https://doi.org/10.1111/joim.12963

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.